Hematology/Oncology

Top Story

Columbia, NewYork-Presbyterian appoint new cancer center director

Columbia, NewYork-Presbyterian appoint new cancer center director
December 15, 2018
Meeting News

MCL-1 dependence may predict response to alvocidib in relapsed, refractory acute myeloid leukemia

December 14, 2018
SAN DIEGO — Researchers investigating potential biomarkers of response to alvocidib found the investigational CDK9 inhibitor had clinical activity against relapsed…
FDA News

FDA approves Herzuma, biosimilar to Herceptin, for breast cancer subset

December 14, 2018
The FDA today approved trastuzumab-pkrb for the treatment of patients with HER2-positive breast cancer, the agency announced in a press release. Trastuzumab-pkrb…
FDA News

FDA approves romiplostim for children with immune thrombocytopenia

December 14, 2018
The FDA today approved romiplostim for treatment of certain pediatric patients with immune thrombocytopenia, according to a press release from the agency. The approval…
Meeting News

Thrombotic events remain low with use of coagulation factor VIIa recombinant

December 14, 2018
The rate of thrombotic events among patients treated with coagulation factor VIIa recombinant within its licensed indications continues to be low and has remained stable…
More Headlines »
CME ABIM MOC

Ace the Case: A 72-Year-Old Man With Fatigue, Weight Loss, and Lymphocytosis

There is no commercial support for this activity.

This educational activity will review the diagnosis and management of a 72-year-old man with complaints of increasing…
More »
Video
Meeting News

VIDEO: CV effects of vitamin D, omega-3 supplements remain unclear

November 24, 2018
More »
Resource Centers
ASH Annual Meeting and Exposition

ASH Annual Meeting and Exposition

CME ABIM MOC

Ace the Case: A 71-Year-Old Man Who Presents With Complaints of Fatigue and Easy Bruisability

There is no commercial support for this activity.

This educational activity will discuss the diagnosis and management of a 71-year-old male who presents to his primary…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next